Intravenous Arginine Administration Downregulates NLRP3 Inflammasome Activity and Attenuates Acute Kidney Injury in Mice with Polymicrobial Sepsis

Acute kidney injury (AKI) is a major complication of sepsis. Nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasomes are multiprotein complexes that mediate septic AKI. L-arginine (Arg) is a conditionally essential amino acid in catabolic conditions and a substrate for nitric oxide (NO) production; however, its use in sepsis is controversial. This study investigated the effect of intravenous Arg supplementation on modulating NLRP3 inflammasome activity in relation to septic AKI. Mice were divided into normal control (NC), sham, sepsis saline (SS), and sepsis Arg (SA) groups. In order to investigate the role of NO, L-N6-(1-iminoethyl)-lysine hydrochloride (L-NIL), an inducible NO synthase inhibitor, was administered to the sepsis groups. Sepsis was induced using cecal ligation and puncture (CLP). The SS and SA groups received saline or Arg via tail vein 1 h after CLP. Mice were sacrificed at 6, 12, and 24 h after sepsis. The results showed that compared to the NC group, septic mice had higher plasma kidney function parameters and lower Arg levels. Also, renal NLRP3 inflammasome protein expression and tubular injury score increased. After Arg treatment, plasma Arg and NO levels increased, kidney function improved, and expressions of renal NLRP3 inflammasome-related proteins were downregulated. Changes in plasma NO and renal NLRP3 inflammasome-related protein expression were abrogated when L-NIL was given to the Arg sepsis groups. Arg plus L-NIL administration also attenuated kidney injury after CLP. The findings suggest that intravenous Arg supplementation immediately after sepsis restores plasma Arg levels and is beneficial for attenuating septic AKI, partly via NO-mediated NLRP3 inflammasome inhibition.

[1]  Nuoyan Zheng,et al.  Roles of Inflammasomes in Inflammatory Kidney Diseases , 2019, Mediators of inflammation.

[2]  L. Michea,et al.  l-NIL prevents the ischemia and reperfusion injury involving TLR-4, GST, clusterin, and NFAT-5 in mice. , 2019, American journal of physiology. Renal physiology.

[3]  Y. H. Lee,et al.  Inflammasome-Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal Injury , 2018, Front. Immunol..

[4]  A. Lau,et al.  Renal immune surveillance and dipeptidase‐1 contribute to contrast‐induced acute kidney injury , 2018, The Journal of clinical investigation.

[5]  C. Yeh,et al.  Arginine pretreatment enhances circulating endothelial progenitor cell population and attenuates inflammatory response in high-fat diet-induced obese mice with limb ischemia. , 2018, Nutrition research.

[6]  H. Anders,et al.  The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury. , 2017, Kidney international.

[7]  C. Yeh,et al.  Intravenous Arginine Administration Promotes Proangiogenic Cells Mobilization and Attenuates Lung Injury in Mice with Polymicrobial Sepsis , 2017, Nutrients.

[8]  S. Yeh,et al.  Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD‐1/PD‐L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis , 2017, JPEN. Journal of parenteral and enteral nutrition.

[9]  R. D. Peluffo,et al.  Threshold levels of extracellular l-arginine that trigger NOS-mediated ROS/RNS production in cardiac ventricular myocytes. , 2017, American journal of physiology. Cell physiology.

[10]  R. Martindale,et al.  Parenteral or Enteral Arginine Supplementation Safety and Efficacy. , 2016, The Journal of nutrition.

[11]  C. Yeh,et al.  Glutamine Administration Modulates Endothelial Progenitor Cell and Lung Injury in Septic Mice , 2016, Shock.

[12]  P. Boor,et al.  An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. , 2016, Kidney international.

[13]  S. Eiam‐Ong,et al.  Serum Neutrophil Gelatinase Associated Lipocalin (NGAL) Outperforms Serum Creatinine in Detecting Sepsis-Induced Acute Kidney Injury, Experiments on Bilateral Nephrectomy and Bilateral Ureter Obstruction Mouse Models , 2016, Shock.

[14]  J. Alvarez‐Leite,et al.  Arginine Supplementation Induces Arginase Activity and Inhibits TNF-α Synthesis in Mice Spleen Macrophages After Intestinal Obstruction. , 2016, JPEN. Journal of parenteral and enteral nutrition.

[15]  Christopher W Seymour,et al.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[16]  Mingwei Chen,et al.  Role of the nucleotide‐binding domain‐like receptor protein 3 inflammasome in acute kidney injury , 2015, The FEBS journal.

[17]  Peng Wang,et al.  Exogenous Carbon Monoxide Decreases Sepsis-Induced Acute Kidney Injury and Inhibits NLRP3 Inflammasome Activation in Rats , 2015, International journal of molecular sciences.

[18]  A. Kandhare,et al.  l-Arginine attenuates the ethylene glycol induced urolithiasis in ininephrectomized hypertensive rats: role of KIM-1, NGAL, and NOs , 2015, Renal failure.

[19]  R. Martindale,et al.  Evolving paradigms in the nutritional support of critically ill surgical patients. , 2015, Current problems in surgery.

[20]  M. Poeze,et al.  Arginine and Citrulline and the Immune Response in Sepsis , 2015, Nutrients.

[21]  Z. Dong,et al.  Mangiferin Attenuate Sepsis-Induced Acute Kidney Injury via Antioxidant and Anti-Inflammatory Effects , 2014, American Journal of Nephrology.

[22]  J. Kellum,et al.  A Unified Theory of Sepsis-Induced Acute Kidney Injury: Inflammation, Microcirculatory Dysfunction, Bioenergetics, and the Tubular Cell Adaptation to Injury , 2014, Shock.

[23]  M. Bottai,et al.  Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction , 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[24]  R. Hotchkiss,et al.  Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. , 2013, American journal of respiratory and critical care medicine.

[25]  Yingwei Chen,et al.  Curcumin suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock. , 2013, Molecular nutrition & food research.

[26]  Yan Zeng,et al.  Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock , 2013, Cell Research.

[27]  H. Anders,et al.  Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. , 2013, The Journal of clinical investigation.

[28]  S. Akira,et al.  Cutting Edge: Nitric Oxide Inhibits the NLRP3 Inflammasome , 2012, The Journal of Immunology.

[29]  N. Câmara,et al.  Pivotal Role of Toll-Like Receptors 2 and 4, Its Adaptor Molecule MyD88, and Inflammasome Complex in Experimental Tubule-Interstitial Nephritis , 2011, PloS one.

[30]  Guoyao Wu,et al.  Regulatory role for l-arginine in the utilization of amino acids by pig small-intestinal bacteria , 2011, Amino Acids.

[31]  N. Deutz,et al.  Effects of L-arginine pretreatment on nitric oxide metabolism and hepatosplanchnic perfusion during porcine endotoxemia. , 2011, The American journal of clinical nutrition.

[32]  N. Câmara,et al.  THE ROLE OF INNATE IMMUNITY IN SEPTIC ACUTE KIDNEY INJURIES , 2010, Shock.

[33]  M. Eşrefoğlu,et al.  Effect of resveratrol on tubular damage and interstitial fibrosis in kidneys of rats exposed to cigarette smoke , 2009, Toxicology and industrial health.

[34]  Sung Woo Kim,et al.  Arginine metabolism and nutrition in growth, health and disease , 2009, Amino Acids.

[35]  R. Tompkins,et al.  L-ARGININE ATTENUATES ACUTE LUNG INJURY AFTER SMOKE INHALATION AND BURN INJURY IN SHEEP , 2007, Shock.

[36]  Yu-Chen Hou,et al.  EFFECT OF ARGININE ON CELLULAR ADHESION MOLECULE EXPRESSION AND LEUKOCYTE TRANSMIGRATION IN ENDOTHELIAL CELLS STIMULATED BY BIOLOGICAL FLUID FROM SURGICAL PATIENTS , 2007, Shock.

[37]  H. Zeh,et al.  Arginine and immunity. , 2007, The Journal of nutrition.

[38]  R. Martindale,et al.  Arginine in the critical care setting. , 2007, The Journal of nutrition.

[39]  G. Biolo,et al.  Immunonutrition in septic patients: a philosophical view of the current situation. , 2007, Clinical nutrition.

[40]  R. Bellomo,et al.  Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.

[41]  D. Pizzo,et al.  Production of arginine by the kidney is impaired in a model of sepsis: early events following LPS. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[42]  C. Dejong,et al.  Sepsis: An arginine deficiency state? , 2004, Critical care medicine.

[43]  R. Bellomo,et al.  Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine , 2003, Critical care medicine.

[44]  S. Yeh,et al.  Arginine supplementation enhances peritoneal macrophage phagocytic activity in rats with gut-derived sepsis. , 2003, JPEN. Journal of parenteral and enteral nutrition.

[45]  D. Kim,et al.  Regulation of cytokine production by exogenous nitric oxide in murine splenocyte and peritoneal macrophage , 2000, Archives of pharmacal research.

[46]  T. Billiar,et al.  Nitric Oxide Prevents IL-1β and IFN-γ-Inducing Factor (IL-18) Release from Macrophages by Inhibiting Caspase-1 (IL-1β-Converting Enzyme) , 1998, The Journal of Immunology.

[47]  J. Zweier,et al.  Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Klahr,et al.  Role of arginine in health and in renal disease. , 1994, The American journal of physiology.

[49]  T. Kanneganti,et al.  Pyroptosis , 2022, Reactome.

[50]  N. Deutz,et al.  Arginine infusion in patients with septic shock increases nitric oxide production without haemodynamic instability. , 2015, Clinical science.

[51]  N. Deutz,et al.  The role of arginine in infection and sepsis. , 2005, JPEN. Journal of parenteral and enteral nutrition.

[52]  T. Billiar,et al.  Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme). , 1998, Journal of immunology.